179 related articles for article (PubMed ID: 26956045)
1. The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells.
Romano G; Santi L; Bianco MR; Giuffrè MR; Pettinato M; Bugarin C; Garanzini C; Savarese L; Leoni S; Cerrito MG; Leone BE; Gaipa G; Grassilli E; Papa M; Lavitrano M; Giovannoni R
Oncotarget; 2016 Apr; 7(16):22077-91. PubMed ID: 26956045
[TBL] [Abstract][Full Text] [Related]
2. Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU.
Wang Z; Hopson LM; Singleton SS; Yang X; Jogunoori W; Mazumder R; Obias V; Lin P; Nguyen BN; Yao M; Miller L; White J; Rao S; Mishra L
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166179. PubMed ID: 34082069
[TBL] [Abstract][Full Text] [Related]
3. PAR2 Inhibition Enhanced the Sensitivity of Colorectal Cancer Cells to 5-FU and Reduced EMT Signaling.
Quan Q; Zhong F; Wang X; Chen K; Guo L
Oncol Res; 2019 Jul; 27(7):779-788. PubMed ID: 30841957
[TBL] [Abstract][Full Text] [Related]
4. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
[TBL] [Abstract][Full Text] [Related]
6. The anticancer effect of (1S,2S,3E,7E,11E)-3,7,11, 15-cembratetraen-17,2-olide(LS-1) through the activation of TGF-β signaling in SNU-C5/5-FU, fluorouracil-resistant human colon cancer cells.
Kim EJ; Kang JI; Kwak JW; Jeon CH; Tung NH; Kim YH; Choi CH; Hyun JW; Koh YS; Yoo ES; Kang HK
Mar Drugs; 2015 Mar; 13(3):1340-59. PubMed ID: 25786063
[TBL] [Abstract][Full Text] [Related]
7. Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells.
Moon SU; Kang MH; Sung JH; Kim JW; Lee JO; Kim YJ; Lee KW; Bang SM; Lee JS; Kim JH
Oncol Rep; 2015 Jan; 33(1):185-92. PubMed ID: 25370208
[TBL] [Abstract][Full Text] [Related]
8. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma.
Chow AK; Cheng NS; Lam CS; Ng L; Wong SK; Wan TM; Man JH; Cheung AH; Yau TC; Poon JT; Law WL; Pang RW
Mol Cancer; 2015 Apr; 14():80. PubMed ID: 25884645
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
10. Oligomeric proanthocyanidins (OPCs) from grape seed extract suppress the activity of ABC transporters in overcoming chemoresistance in colorectal cancer cells.
Ravindranathan P; Pasham D; Goel A
Carcinogenesis; 2019 May; 40(3):412-421. PubMed ID: 30596962
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
[TBL] [Abstract][Full Text] [Related]
12. Effect of mTHPC-mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells.
Kukcinaviciute E; Sasnauskiene A; Dabkeviciene D; Kirveliene V; Jonusiene V
Photochem Photobiol Sci; 2017 Jul; 16(7):1063-1070. PubMed ID: 28509917
[TBL] [Abstract][Full Text] [Related]
13. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Li T; Gao F; Zhang XP
Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
15. The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116.
Dabkeviciene D; Jonusiene V; Zitkute V; Zalyte E; Grigaitis P; Kirveliene V; Sasnauskiene A
Med Oncol; 2015 Dec; 32(12):258. PubMed ID: 26519257
[TBL] [Abstract][Full Text] [Related]
16. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression.
Findlay VJ; Wang C; Nogueira LM; Hurst K; Quirk D; Ethier SP; Staveley O'Carroll KF; Watson DK; Camp ER
Mol Cancer Ther; 2014 Nov; 13(11):2713-26. PubMed ID: 25249558
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines.
Plasencia C; Abad A; Martinez-Balibrea E; Taron M
Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A.
Germani A; Matrone A; Grossi V; Peserico A; Sanese P; Liuzzi M; Palermo R; Murzilli S; Campese AF; Ingravallo G; Canettieri G; Tezil T; Simone C
Cancer Lett; 2014 Mar; 344(1):110-118. PubMed ID: 24215867
[TBL] [Abstract][Full Text] [Related]
19. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation.
Ku JL; Park SH; Yoon KA; Shin YK; Kim KH; Choi JS; Kang HC; Kim IJ; Han IO; Park JG
Cancer Lett; 2007 Mar; 247(2):283-92. PubMed ID: 16828225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
